title: Brofaromine vs. maprotiline plus lithium in treatment-resistant depressed outpatients.
authors.forename: E
authors.initials: E
authors.lastname: Hoencamp
authors.forename: P M
authors.initials: PM
authors.lastname: Haffmans
mesh_terms: D003866:Depressive Disorder / Q000188:drug therapy* / Q000523:psychology; D004359:Drug Therapy, Combination; D006801:Humans; D008094:Lithium / Q000008:administration & dosage*; D008376:Maprotiline / Q000008:administration & dosage*; D008996:Monoamine Oxidase Inhibitors; D010865:Pilot Projects; D010880:Piperidines / Q000008:administration & dosage*; D011569:Psychiatric Status Rating Scales
chemical_list: D008996:Monoamine Oxidase Inhibitors; D010880:Piperidines; D008376:Maprotiline; C038213:brofaromine; D008094:Lithium